Last year a South African woman took a multibillion-dollar United States pharmaceutical company to court with the aim of securing access to life-changing cystic fibrosis medicines. That case has now been dropped following a reduction in the price charged for the medicines in South Africa. Catherine Tomlinson reports.
Johannesburg-based investment banker Cheri Nel is the driving force behind a court case that may result in dramatically expanded access to life-changing new cystic fibrosis (CF) medicines. Biénne Huisman asked Nel about the motivation behind the court case and what it is like to live with CF.
As a rebellious teenager growing up in the British town of Harpenden, Professor Helen Rees would sneak out to attend anti-apartheid talks. Today, she is a renowned scientist and chair of South Africa’s medicines regulator. Biénne Huisman chatted to Rees about her career, prioritising women’s reproductive health, and her role at the South African Health Products Regulatory Authority.
Whether a pharmacist suggests it for treating headaches or whether a doctor prescribes it for managing post-surgical pain, chances are good that at some point you’ve taken a pain pill containing the opioid codeine. But since codeine can be addictive and withdrawal symptoms severe, regulation of the drug in South Africa has turned into a headache. Elri Voigt takes an in-depth look at the complexities of codeine regulation.
